↓ Skip to main content

Benefits and Risks of HMG-CoA Reductase Inhibitors in the Prevention of Coronary Heart Disease

Overview of attention for article published in Drug Safety, October 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

policy
2 policy sources
patent
1 patent

Citations

dimensions_citation
92 Dimensions

Readers on

mendeley
21 Mendeley
Title
Benefits and Risks of HMG-CoA Reductase Inhibitors in the Prevention of Coronary Heart Disease
Published in
Drug Safety, October 2012
DOI 10.2165/00002018-199614010-00003
Pubmed ID
Authors

Terje R. Pedersen, Jonathan A. Tobert

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 5%
Unknown 20 95%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 5 24%
Student > Ph. D. Student 4 19%
Researcher 4 19%
Professor 2 10%
Librarian 1 5%
Other 2 10%
Unknown 3 14%
Readers by discipline Count As %
Medicine and Dentistry 8 38%
Biochemistry, Genetics and Molecular Biology 4 19%
Pharmacology, Toxicology and Pharmaceutical Science 2 10%
Social Sciences 2 10%
Agricultural and Biological Sciences 1 5%
Other 1 5%
Unknown 3 14%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 November 2010.
All research outputs
#3,799,086
of 25,374,917 outputs
Outputs from Drug Safety
#414
of 1,852 outputs
Outputs of similar age
#27,977
of 202,006 outputs
Outputs of similar age from Drug Safety
#139
of 767 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,852 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.9. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 202,006 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 767 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.